We are happy to invite you to the 8th meeting of Pharmacometrics Network
Please mark the following date and time in your agenda:
When: Thursday, April 14th 2015 – 12:00 – 18:00
Where: hosted by KU Leuven, Belgium (Justus Lipsiuszaal at Faculteit Letteren)
Blijde Inkomststraat, 21
For information on parking, you can click this link:
Agenda theme: “Biomarkers or Clinical Endpoints? Or Both ?”
Registration: you can already register by sending an e-mail to
There is no registration fee, but registration is required for participation.
You can register until April 8th.
*** CALL FOR SPONSORS***: we are looking for organizations willing to fund this
current meeting. We all appreciate the opportunity of the PMX BNL meetings for
good science and good networking, please help us to keep it going. Please
contact me (anne.broc...@ablynx.com<mailto:anne.broc...@ablynx.com>) if you
want to participate.
The meeting will include a light lunch, a coffee/tea break and drinks upon
To be announced
*** CALL FOR PRESENTERS***: we are looking for volunteers to present some
modeling work related to biomarkers and clinical endpoints modeling, please
contact sross...@its.jnj.com<mailto:sross...@its.jnj.com> by February 19th if
you want to participate.
We hope to see you in Leuven on April 14th !
Charlotte van Kesteren
Jan-Stefan van der Walt
On Pharmacometrics Network Benelux: the initiative aims to connect
pharmacometricians in the Benelux (Belgium, Netherlands, and Luxembourg). The
intention is to create an informal platform for the pharmacometrics community
in this region of the world (in industry, academia, hospital pharmacies as well
as regulatory bodies), with the goal to promote professional and scientific
awareness and interactions.
Stay tuned on our latest activity by joining our group on LinkedIn.
THIS E-MAIL MESSAGE IS INTENDED ONLY FOR THE USE OF THE INDIVIDUAL OR ENTITY TO
WHICH IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED,
CONFIDENTIAL AND EXEMPT FROM DISCLOSURE.
If the reader of this E-mail message is not the intended recipient, you are
hereby notified that any dissemination, distribution or copying of this
communication is strictly prohibited. If you have received this communication
in error, please notify us immediately at abl...@ablynx.com. Thank you for your
"NANOBODY" and "NANOCLONE" are registered trademarks of Ablynx N.V.